trimethyloxamine has been researched along with Cognitive Decline in 14 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with higher choline and betaine levels had lower risk of cognitive impairment after ischemic stroke, supporting promising prognostic roles of choline pathway nutrients for poststroke cognitive impairment." | 9.41 | Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke. ( Bu, X; Che, B; Ju, Z; Lu, Z; Qian, S; Wang, A; Xu, T; Zhang, J; Zhang, Y; Zheng, X; Zhong, C, 2021) |
| "Patients with higher choline and betaine levels had lower risk of cognitive impairment after ischemic stroke, supporting promising prognostic roles of choline pathway nutrients for poststroke cognitive impairment." | 5.41 | Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke. ( Bu, X; Che, B; Ju, Z; Lu, Z; Qian, S; Wang, A; Xu, T; Zhang, J; Zhang, Y; Zheng, X; Zhong, C, 2021) |
| "There is increasing evidence for the association of trimethylamine-N-oxide (TMAO) with cognitive impairment after minor stroke or transient ischemic attack (TIA)." | 4.31 | Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack. ( Bao, Y; Huang, D; Jiang, L; Qv, S; Wang, J; Wang, L; Xu, G; Yang, J; Zhan, X, 2023) |
| "We examined prospective associations of TMAO, γ-butyrobetaine, crotonobetaine, carnitine, choline, and betaine with risk of cognitive impairment and dementia among older adults aged 65 years and older in the Cardiovascular Health Study (CHS)." | 4.12 | Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study. ( de Oliveira Otto, MC; Fretts, A; Hazen, SL; Lai, HTM; Lee, Y; Lemaitre, RN; Li, XS; Lopez, O; Mozaffarian, D; Nemet, I; Newman, AB; Siscovick, DS; Tang, WHW; Wang, M; Wang, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 10 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| de Oliveira Otto, MC | 1 |
| Li, XS | 1 |
| Wang, Z | 1 |
| Siscovick, DS | 1 |
| Newman, AB | 1 |
| Lai, HTM | 1 |
| Nemet, I | 1 |
| Lee, Y | 1 |
| Wang, M | 1 |
| Fretts, A | 1 |
| Lemaitre, RN | 1 |
| Tang, WHW | 1 |
| Lopez, O | 1 |
| Hazen, SL | 1 |
| Mozaffarian, D | 1 |
| Buawangpong, N | 1 |
| Pinyopornpanish, K | 1 |
| Phrommintikul, A | 1 |
| Chindapan, N | 1 |
| Devahastin, S | 1 |
| Chattipakorn, N | 1 |
| Chattipakorn, SC | 1 |
| Deng, Y | 3 |
| Zou, J | 3 |
| Hong, Y | 3 |
| Peng, Q | 3 |
| Fu, X | 3 |
| Duan, R | 3 |
| Chen, J | 3 |
| Chen, X | 3 |
| Zhang, Y | 4 |
| Wang, G | 3 |
| Li, R | 3 |
| Liu, R | 3 |
| Yu, Z | 3 |
| Zhang, Z | 3 |
| Wan, Z | 3 |
| Tu, R | 1 |
| Xia, J | 1 |
| Wang, L | 1 |
| Zhan, X | 1 |
| Jiang, L | 2 |
| Xu, G | 1 |
| Bao, Y | 1 |
| Wang, J | 1 |
| Qv, S | 1 |
| Yang, J | 1 |
| Huang, D | 1 |
| Liu, J | 2 |
| Zhou, S | 1 |
| Wang, Y | 1 |
| Sun, S | 1 |
| Sun, Y | 1 |
| Xu, P | 1 |
| Xu, X | 1 |
| Zhu, B | 1 |
| Wu, H | 1 |
| Zhu, C | 1 |
| Li, G | 1 |
| Lv, Z | 1 |
| Li, J | 1 |
| Wang, X | 1 |
| Kang, J | 1 |
| Zhan, C | 1 |
| Zhao, L | 1 |
| Zhang, C | 1 |
| Cao, G | 1 |
| Dong, X | 1 |
| Li, D | 3 |
| Tan, AH | 1 |
| Chong, CW | 1 |
| Lim, SY | 1 |
| Yap, IKS | 1 |
| Teh, CSJ | 1 |
| Loke, MF | 1 |
| Song, SL | 1 |
| Tan, JY | 1 |
| Ang, BH | 1 |
| Tan, YQ | 1 |
| Kho, MT | 1 |
| Bowman, J | 1 |
| Mahadeva, S | 1 |
| Yong, HS | 1 |
| Lang, AE | 1 |
| Zhong, C | 1 |
| Lu, Z | 1 |
| Che, B | 1 |
| Qian, S | 1 |
| Zheng, X | 1 |
| Wang, A | 1 |
| Bu, X | 1 |
| Zhang, J | 1 |
| Ju, Z | 1 |
| Xu, T | 1 |
| Ke, Y | 1 |
| Zhan, R | 1 |
| Liu, C | 1 |
| Zhao, M | 1 |
| Zeng, A | 1 |
| Shi, X | 1 |
| Ji, L | 1 |
| Cheng, S | 1 |
| Pan, B | 1 |
| Zheng, L | 1 |
| Hong, H | 1 |
| Vogt, NM | 1 |
| Romano, KA | 1 |
| Darst, BF | 1 |
| Engelman, CD | 1 |
| Johnson, SC | 1 |
| Carlsson, CM | 1 |
| Asthana, S | 1 |
| Blennow, K | 1 |
| Zetterberg, H | 1 |
| Bendlin, BB | 1 |
| Rey, FE | 1 |
| Meng, F | 1 |
| Li, N | 1 |
| Song, B | 1 |
| Li, L | 1 |
1 review available for trimethyloxamine and Cognitive Decline
| Article | Year |
|---|---|
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO.
Topics: Choline; Cognitive Dysfunction; Gastrointestinal Microbiome; Humans; Inflammation; Stroke; Thrombosi | 2024 |
1 trial available for trimethyloxamine and Cognitive Decline
| Article | Year |
|---|---|
Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; China; Choline; Cognition; Cognition Disorders; Cogni | 2021 |
12 other studies available for trimethyloxamine and Cognitive Decline
| Article | Year |
|---|---|
Longitudinal Associations of Plasma TMAO and Related Metabolites with Cognitive Impairment and Dementia in Older Adults: The Cardiovascular Health Study.
Topics: Animals; Betaine; Carnitine; Choline; Cognitive Dysfunction; Dementia; Medicare; Methylamines; Unite | 2022 |
Increased plasma trimethylamine-
Topics: Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cognitive Dysfunction; Heart Disease Risk | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
Topics: Animals; Cognitive Dysfunction; Dementia, Vascular; Hippocampus; Inflammation; Rats; Sirtuin 1; Vasc | 2022 |
Trimethylamine N-oxide aggravated cognitive impairment from APP/PS1 mice and protective roles of voluntary exercise.
Topics: Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Betaine; Brain-Derived | 2023 |
Trimethylamine N-oxide aggravated cognitive impairment from APP/PS1 mice and protective roles of voluntary exercise.
Topics: Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Betaine; Brain-Derived | 2023 |
Trimethylamine N-oxide aggravated cognitive impairment from APP/PS1 mice and protective roles of voluntary exercise.
Topics: Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Betaine; Brain-Derived | 2023 |
Trimethylamine N-oxide aggravated cognitive impairment from APP/PS1 mice and protective roles of voluntary exercise.
Topics: Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Betaine; Brain-Derived | 2023 |
Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack.
Topics: Aged; Cognitive Dysfunction; Humans; Ischemic Attack, Transient; Male; Oxides; Retrospective Studies | 2023 |
ZeXieYin Formula alleviates TMAO-induced cognitive impairment by restoring synaptic plasticity damage.
Topics: Animals; Cognitive Dysfunction; Learning; Mice; Neuronal Plasticity; TOR Serine-Threonine Kinases | 2023 |
Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Cognitive Dysfunction; Female; Follow-Up Studie | 2020 |
Higher Circulating Trimethylamine N-oxide Sensitizes Sevoflurane-Induced Cognitive Dysfunction in Aged Rats Probably by Downregulating Hippocampal Methionine Sulfoxide Reductase A.
Topics: Animals; Cognitive Dysfunction; Down-Regulation; Fear; Hippocampus; Inflammation; Interleukin-1beta; | 2019 |
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Topics: Aged; Ceramides; Chromatography, Liquid; Cognitive Dysfunction; Constipation; Fatty Acids, Volatile; | 2021 |
Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice.
Topics: Adolescent; Adult; Aged; Animals; Brain; Cellular Senescence; Cognitive Dysfunction; Humans; Male; M | 2018 |
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Gastroint | 2018 |
The presence of elevated circulating trimethylamine N-oxide exaggerates postoperative cognitive dysfunction in aged rats.
Topics: Age Factors; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Gastrointestinal Microbi | 2019 |